These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18455518)

  • 1. Lysophosphatidic acid and renal fibrosis.
    Pradère JP; Gonzalez J; Klein J; Valet P; Grès S; Salant D; Bascands JL; Saulnier-Blache JS; Schanstra JP
    Biochim Biophys Acta; 2008 Sep; 1781(9):582-7. PubMed ID: 18455518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.
    Sakai N; Chun J; Duffield JS; Lagares D; Wada T; Luster AD; Tager AM
    Kidney Int; 2017 Mar; 91(3):628-641. PubMed ID: 27927603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPA1 receptor activation promotes renal interstitial fibrosis.
    Pradère JP; Klein J; Grès S; Guigné C; Neau E; Valet P; Calise D; Chun J; Bascands JL; Saulnier-Blache JS; Schanstra JP
    J Am Soc Nephrol; 2007 Dec; 18(12):3110-8. PubMed ID: 18003779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lysophosphatidic acid and its receptors in the kidney.
    Park F; Miller DD
    Physiol Genomics; 2017 Nov; 49(11):659-666. PubMed ID: 28939644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.
    Tager AM; LaCamera P; Shea BS; Campanella GS; Selman M; Zhao Z; Polosukhin V; Wain J; Karimi-Shah BA; Kim ND; Hart WK; Pardo A; Blackwell TS; Xu Y; Chun J; Luster AD
    Nat Med; 2008 Jan; 14(1):45-54. PubMed ID: 18066075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.
    González de San Román E; Manuel I; Giralt MT; Chun J; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Ferrer I; Rodríguez-Puertas R
    J Neurochem; 2015 Aug; 134(3):471-85. PubMed ID: 25857358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis Pathogenesis.
    Fransson J; Gómez-Conde AI; Romero-Imbroda J; Fernández O; Leyva L; de Fonseca FR; Chun J; Louapre C; Van-Evercooren AB; Zujovic V; Estivill-Torrús G; García-Díaz B
    Mol Neurobiol; 2021 Feb; 58(2):470-482. PubMed ID: 32974731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.
    Sakai N; Chun J; Duffield JS; Wada T; Luster AD; Tager AM
    FASEB J; 2013 May; 27(5):1830-46. PubMed ID: 23322166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
    Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells.
    Ren Y; Guo L; Tang X; Apparsundaram S; Kitson C; Deguzman J; Fuentes ME; Coyle L; Majmudar R; Allard J; Truitt T; Hamid R; Chen Y; Qian Y; Budd DC
    Microvasc Res; 2013 Jan; 85():59-67. PubMed ID: 23084965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic Acid Signaling through the Lysophosphatidic Acid-1 Receptor Is Required for Alveolarization.
    Funke M; Knudsen L; Lagares D; Ebener S; Probst CK; Fontaine BA; Franklin A; Kellner M; Kühnel M; Matthieu S; Grothausmann R; Chun J; Roberts JD; Ochs M; Tager AM
    Am J Respir Cell Mol Biol; 2016 Jul; 55(1):105-16. PubMed ID: 27082727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
    Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
    Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Regulation of Lysophosphatidic Acid Receptor 1 Maturation and Desensitization.
    Zhao J; Stephens T; Zhao Y
    Cell Biochem Biophys; 2021 Sep; 79(3):477-483. PubMed ID: 34032994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous lysophosphatidic acid (LPA
    Sattikar A; Dowling MR; Rosethorne EM
    Br J Pharmacol; 2017 Feb; 174(3):227-237. PubMed ID: 27864940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of silicosis formation by lysophosphatidic acid and its receptors.
    Cong C; Mao L; Zhang Y; Zhao Z; Xu X; Zhao J
    Exp Lung Res; 2014 Sep; 40(7):317-26. PubMed ID: 24926730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential anatomical and cellular expression of lysophosphatidic acid receptor 1 in adult mouse brain.
    Kajitani N; Okada-Tsuchioka M; Kano K; Omori W; Boku S; Aoki J; Takebayashi M
    Biochem Biophys Res Commun; 2020 Oct; 531(2):89-95. PubMed ID: 32718668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid and its receptor LPA
    Srikanth M; Chew WS; Hind T; Lim SM; Hay NWJ; Lee JHM; Rivera R; Chun J; Ong WY; Herr DR
    Eur J Pharmacol; 2018 Dec; 841():49-56. PubMed ID: 30321532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical Control of Lysophosphatidic Acid Signaling.
    Morstein J; Dacheux MA; Norman DD; Shemet A; Donthamsetti PC; Citir M; Frank JA; Schultz C; Isacoff EY; Parrill AL; Tigyi GJ; Trauner D
    J Am Chem Soc; 2020 Jun; 142(24):10612-10616. PubMed ID: 32469525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid-1-receptor targeting agents for fibrosis.
    Rancoule C; Pradère JP; Gonzalez J; Klein J; Valet P; Bascands JL; Schanstra JP; Saulnier-Blache JS
    Expert Opin Investig Drugs; 2011 May; 20(5):657-67. PubMed ID: 21434838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.